Company intelligence / Profile preview

Xcess Biosciences

Chicago, Illinois, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Xcess Biosciences specializes in custom synthesis of small molecules, lead optimization, and supplies chemical reagents such as the GSK3β inhibitor CHIR99021 that are widely used in stem cell and Wnt pathway research, with proven capability in both medicinal and process chemistry for pharma and biotech clients

Therapeutic areas: HematologyNeurologyOther
Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Cedarlane (distribution and manufacturing partner)Cosmo Bio Co., Ltd (distribution)

Beyond the preview

Go deeper on Xcess Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xcess Biosciences.

Explore the full profile